Literature DB >> 25972958

Metaplastic conus meningioma and its applied aspects.

Srikanth Reddy1, Aneel Kumar Pulligopu1, Ashish Kumar1, Barada Prasad Sahu1.   

Abstract

Cranial meningiomas may present with or without major deficits depending on their location and morphology. Spinal meningiomas account for 25% of all the spinal tumors. Most commonly encountered in the dorsal spine in middle-aged females, these intradural-extramedullary tumors can usually be excised without difficulty. Rarely, they can be encountered in the lumbar spine and may create many tactical problems for the surgical team especially if it is calcified and contains metaplastic bone. We report a 55-year-old patient who presented with backache and investigations revealed a calcified lesion at L1 level that was thought of as an ependymoma initially. Intraoperatively, the lesion was calcified in parts, and the histopathology revealed it to be a metaplastic meningioma with calcification. The patient had a transient hip weakness, which recovered completely later on. Calcification in meningiomas is common. However, frank bony metaplasia is extremely rare. More importantly, the applied aspect of their presence in the region of conus lies in the careful dissection to prevent damage to the surrounding neural structures. Awareness regarding the same may help us preventing complications in the future.

Entities:  

Keywords:  Calcification; conus; metaplastic meningioma

Year:  2015        PMID: 25972958      PMCID: PMC4421964          DOI: 10.4103/1793-5482.153498

Source DB:  PubMed          Journal:  Asian J Neurosurg


Introduction

Spinal meningiomas are the second only to tumors of the nerve sheath in the intradural-extramedullary location. They account for approximately 25% of all spinal tumors. Approximately, 80% of spinal meningiomas are located in the thoracic spine, followed by cervical spine (15%), lumbar spine (3%), and near foramen magnum (2%).[123] Based on location, lumbar meningiomas constitute merely 2–3% of all spinal tumors. We hereby present a case of 55-year-old lady presenting with persistent low backache diagnosed to have intradural-extramedullary calcified metaplastic meningioma at L1 undergoing complete surgical excision of the lesion.

Case Report

A 55-year-old female patient consulted us with persisting dull aching low backache for past 2 months, radiating along the posterior aspect of her right thigh. Pain aggravated with lying down in the supine position for prolonged periods and was relieved in sitting a position and partially with analgesics. Her neurological examination was within normal limits. Magnetic resonance imaging showed a solitary intradural-extramedullary iso-intense lesion on T1 and T2-weighted images, homogenously enhancing on contrast measuring 3 cm × 2 cm, located at L1 region pushing the conus medullaris to left side [Figure 1]. A presumptive diagnosis of ependymoma was made. Patient underwent D12 and L1 laminectomy, exposing normal dura above and below the lesion. Dura was opened lateral to lesion towards the left side to avoid injury to conus-cauda and nerve rootlets. Tumor was brownish red, soft in the center and firm to hard in consistency as we proceeded outwards. The calcified peripheral parts had to be cut with a scalpel after protecting the roots and only then the tumor was completely excised. Adherent part of the tumor to dura was excised, and the dural base was coagulated. Histology showed frank bony trabeculae within the meningioma. The lesion was compromising of spindle cells arranged in whirling pattern and in syncytical pattern. Metaplastic bone was seen along with psammomatous calcification [Figure 2]. Mitosis was sparse 0–1/10 HPF. There was no necrosis. Progesterone receptor status was negative, and Ki 67 index showed a labeling index of <1%; features consistent with Metaplastic Meningioma. Postoperatively patient had mild weakness of hip flexion (4/5) that improved over next 3 days with physiotherapy. At present patient is asymptomatic and under our follow-up for 3 months.
Figure 1

Magnetic resonance imaging lumbar spine showing the lesion that is iso-intense on T1-weighted and extremely hypointense on T2-weighted imaging along with homogenous contrast enhancement evident on sagittal and axial images

Figure 2

The histopathology showing spindle cells arranged in whorls and syncitial pattern along with the presence of frank ossification with chondrocytes

Magnetic resonance imaging lumbar spine showing the lesion that is iso-intense on T1-weighted and extremely hypointense on T2-weighted imaging along with homogenous contrast enhancement evident on sagittal and axial images The histopathology showing spindle cells arranged in whorls and syncitial pattern along with the presence of frank ossification with chondrocytes

Discussion

Meningiomas are the most common benign intracranial tumors arising from arachnoid cap cells. Spinal meningiomas though not uncommon account for approximately 0.75–12.7% of all meningiomas[456] and about 25–46% of total spinal cord tumors.[78] These lesions most commonly involve the thoracic region (67–84%) and encountered least commonly in the lumbar region (2–10%).[23] Meningiomas presenting as primary tumors of the intradural conus and cauda equina region are still rare, and these represent only 2% of all spinal cord meningiomas.[245] Overall incidence is common among middle-aged women, but the sex incidence is equal in the lumbosacral region.[9] Our patient presented with only dull aching backache. As spinal meningiomas are generally slow growing benign tumors, neurological deficits or gait disturbances appear following significant spinal cord compression mostly at an advanced stage of the disease. Hence, these unspecific symptoms such as local pain are often misinterpreted until the diagnosis is confirmed by neuroimaging procedures[101112] like in our case. Metaplasia of the arachnoid cells has been proposed as the etiology of ossification by some and others favored dystrophic calcification as the pathogenesis.[13] Psammoma bodies are especially frequent in spinal meningiomas.[14] Approximately 50–90% of spinal meningiomas have psammoma bodies compared with only 10% of the intracranial form.[15] Where they are particularly numerous, they have a tendency to fuse and form calcium spicules. The gradual confluence of calcium deposits can give the meningioma a rock-like consistency,[16] like in our case where metaplastic bone formation was noted along with psammomatous calcification. The quintessential surgical challenge in our case was to excise it piecemeal where the tumor had to be cut with scalpel and underlying adherent rootlets needed to be separated with great care under microscope. But still patient ended up having hip flexion weakness that gradually improved with physiotherapy, this emphasizing the eloquent nature of underlying structures. Many investigators have stated that calcification of meningioma is another variable in tumor recurrence as it adds to incomplete removal of the tumor.[71718] Also, outcome following surgery for metaplastic spinal meningioma can be good, despite the severity of the pre and intraoperative condition; however, highly calcified tumors may bear a poor prognosis.[718] At times, it is mentioned that a calcified anterior spinal, thoracic meningioma should be managed like a calcified disk herniation despite the increased risk of cerebrospinal fluid leakage.[1920] Therefore, the detection of metaplastic bone within a meningioma is important to estimate the difficulty of resection and thereby improving the postoperative prognosis by careful intra-operative handling in eloquent region like conus.
  19 in total

1.  Hard-rock spinal meningioma. Case report and review of the literature.

Authors:  P Lunardi; P Missori; C Franco; R Delfini; A Fortuna
Journal:  J Neurosurg Sci       Date:  1992 Oct-Dec       Impact factor: 2.279

Review 2.  Extramedullary intradural spinal tumors: a review of modern diagnostic and treatment options and a report of a series.

Authors:  Kenan Arnautovic; Aska Arnautovic
Journal:  Bosn J Basic Med Sci       Date:  2009-10       Impact factor: 3.363

3.  Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas.

Authors:  Okay Saydam; Ozlem Senol; Tieneke B M Schaaij-Visser; Thang V Pham; Sander R Piersma; Anat O Stemmer-Rachamimov; Thomas Wurdinger; Saskia M Peerdeman; Connie R Jimenez
Journal:  J Proteome Res       Date:  2010-01       Impact factor: 4.466

Review 4.  Ossified thoracic spinal meningioma in childhood: a case report and review of the literature.

Authors:  S Naderi; M Yilmaz; T Canda; U Acar
Journal:  Clin Neurol Neurosurg       Date:  2001-12       Impact factor: 1.876

5.  Roentgenographically visible calcifications in spinal meningioma.

Authors:  B L Pear; H R Boyd
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1974-01

6.  Intradural conus and cauda equina tumours: a retrospective review of presentation, diagnosis and early outcome.

Authors:  P Mathew; N V Todd
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-01       Impact factor: 10.154

7.  Recurrent calcified spinal meningioma detected by plain radiograph.

Authors:  M Doita; T Harada; K Nishida; T Marui; M Kurosaka; S Yoshiya
Journal:  Spine (Phila Pa 1976)       Date:  2001-06-01       Impact factor: 3.468

Review 8.  Spinal epidural en-plaque meningioma with an unusual pattern of calcification in a 14-year-old girl: case report and review of the literature.

Authors:  A Messori; F Rychlicki; U Salvolini
Journal:  Neuroradiology       Date:  2002-03       Impact factor: 2.804

9.  Results in the operative treatment of elderly patients with spinal meningiomas.

Authors:  Xavier Morandi; Claire Haegelen; Laurent Riffaud; Seyed Amlashi; Mahmoudreza Adn; Gilles Brassier
Journal:  Spine (Phila Pa 1976)       Date:  2004-10-01       Impact factor: 3.468

10.  Exophytic intramedullary meningioma of the cervical spinal cord.

Authors:  D Sahni; J S Harrop; I H Kalfas; A R Vaccaro; D Weingarten
Journal:  J Clin Neurosci       Date:  2008-08-16       Impact factor: 1.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.